- Delta 9 Cannabis (DN) has announced its first export of dried cannabis flower material to a customer in Australia
- The company received seven additional export permits from Health Canada and intends to continue shipping dried cannabis flower and cannabis extracts to Australia
- Delta 9 views the international market as an emerging opportunity to increase revenue from its cannabis operations
- Delta 9 Cannabis is a vertically-integrated cannabis company operating through medical and recreational sales channels
- Delta 9 Cannabis Inc. (DN) opened trading at C$0.075
Delta 9 Cannabis (DN) has announced its first export of dried cannabis flower material to a customer in Australia.
Having received seven additional export permits from Health Canada, the company intends to complete multiple shipments of dried cannabis flower and cannabis extracts to the Australian market in the first and second quarters of 2023. The shipments are anticipated to include approximately 100 Kg of dried cannabis flower material and 6 Kg of cannabis distillate.
“This shipment is our first step of many planned sales into the Australian medical cannabis market,” said John Arbuthnot, CEO of Delta 9.
“We see significant emerging market opportunities in international markets playing out over the next several years and anticipate that exports of cannabis products will become a key growth driver for us.”
Delta 9 views the international market as an emerging opportunity to increase revenue from its cannabis operations. The company believes that an increasing number of global markets will refine regulations, allowing for lower-barrier access to high-quality cannabis products produced by trusted suppliers from Canada.
Delta 9 Cannabis is a vertically-integrated cannabis company operating through medical and recreational sales channels.
Delta 9 Cannabis Inc. (DN) opened trading at C$0.075.